Outcomes of primary percutaneous coronary intervention in acute myocardial infarction at Tehran Heart Center

Medical Principles and Practice

Volumn 16, Issue 5, 2007, Pages 333-338

  Alidoosti, Mohammad ^a   Salarifar, Mojtaba ^a   Hajizeinali, Alimohammad ^a   Kassaian, Seyed Ebrahim ^a   Kasemisaleh, Davood ^a   Goodarzynejad, Hamidreza ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Major adverse cardiac events; Primary percutaneous coronary intervention; ST segment myocardial infarction

Indexed keywords

PACLITAXEL;

ACUTE HEART INFARCTION; ADULT; AGED; ANGIOGRAPHY; ANGIOPLASTY; ARTICLE; BALLOON DILATATION; BLOOD CLOT LYSIS; CARDIOGENIC SHOCK; CONTROLLED STUDY; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PERFUSION; ST SEGMENT ELEVATION; STENT; TIME SERIES ANALYSIS; TREATMENT OUTCOME; VASCULAR PATENCY;

ADULT; AGED; AGED, 80 AND OVER; ANGIOPLASTY, BALLOON, CORONARY; COMORBIDITY; FEMALE; HOSPITAL MORTALITY; HUMANS; IRAN; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); RECURRENCE; SHOCK, CARDIOGENIC; STROKE; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 34548118674     PISSN: 10117571     EISSN: None     Source Type: Journal    
DOI: 10.1159/000104804     Document Type: Article

References (24)

1. Meyer J, Merx W, Dorr R, Lambertz H, Bethge C, Effert S: Successful treatment of acute myocardial infarction shock by combined percutaneous transluminal coronary recanalization and percutaneous transluminal coronary angioplasty. Am Heart J 1982;103:132-113.
2. Hartzler GO, Rutherford BD, McConahay DR, Johnson WL Jr, McCallister BD, Gura GM Jr, Conn RC, Crockett JE: Percutaneous transluminal coronary angioplasty with and without thrombolytic therapy for treatment of acute myocardial infarction. Am Heart J 1983;106:965-973.
3. Keeley EC, Boura JA, Grines CL: Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet 2003;361:13-20.
4. The TIMI Study Group: Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction: results of the TIMI IIIB Trial. Thrombolysis in Myocardial Ischemia. Circulation 1994;89:1545-1556.
5. Rogers WJ, Bowlby LJ, Chandra NC, French WJ, Gore JM, Lambrew CT, Rubison RM, Tiefenbrunn AJ, Weaver WD: Treatment of myocardial infarction in the United States (1990 to 1993). Observations from the National Registry of Myocardial Infarction. Circulation 1994;90:2103-2114.
6. Reeder GS, Bailey KR, Gersh BJ, Holmes DR Jr, Christianson J, Gibbons RJ: Cost comparison of immediate angioplasty versus thrombolysis followed by conservative therapy for acute myocardial infarction: a randomized prospective trial. Mayo Coronary Care Unit and Catheterization Laboratory Groups. Mayo Clin Proc 1994;69:5-12.
7. Stone GW, Grines CL, Rothbaum D, Browne KF, O'Keefe J, Overlie PA, Donohue BC, Chelliah N, Vlietstra R, Catlin T, O'Neill WW: Analysis of the relative costs and effectiveness of primary angioplasty compared to tissue plasminogen activator: the Primary Angioplasty in Myocardial Infarction (PAMI) trial. J Am Coll Cardiol 1997;901-907.
8. Armstrong PW, Collen D: Fibrinolysis for acute myocardial infarction: current status and new horizons for pharmacological reperfusion, part 2. Circulation 2001;103:2987-2992.
9. Guidelines for percutaneous transluminal coronary angioplasty: a report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee on Percutaneous Transluminal Coronary Angioplasty). J Am Coll Cardiol 1988;12:529-545.
10. O'Keefe JH Jr, Rutherford BD, McConahay DR, Ligon RW, Johnson WL Jr, Giorgi LV, Crockett JE, McCallister BD, Conn RD, Gura GM Jr: Early and late results of coronary angioplasty without antecedent thrombolytic therapy for acute myocardial infarction. Am J Cardiol 1989;64:1221-1230.
11. Rothbaum DA, Linnemeier TJ, Landin RJ, Steinmetz EF, Hillis JS, Hallam CC, Noble RJ, See MR: Emergency percutaneous transluminal coronary angioplasty in acute myocardial infarction: a 3 year experience. J Am Coll Cardiol 1987;10:264-272.
12. Chesebro JH, Knatterud G, Roberts R, Borer J, Cohen LS, Dalen J, Dodge HT, Francis CK, Hillis D, Ludbrook P: Thrombolysis in Myocardial Infarction (TIMI) trial. Phase 1: a comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge. Circulation 1987;76:142-154.
13. Verstraete M, Bernard R, Bory M, Brower RW, Collen D, de Bono DP, Erbel R, Huhmann W, Lennane RJ, Lubsen J: Randomized trial of intravenous recombinant tissue-type plasminogen activator versus intravenous streptokinase in acute myocardial infarction. Report from the European Cooperative Study Group. Lancet 1985;1:842-847.
14. Collen D, Van de Werf F: Coronary arterial thrombolysis with low-dose synergistic combinations of recombinant tissue-type plasminogen activator [t-PA] and recombinant single-chain urokinase-type plasminogen activator (rscu-PA) for acute myocardial infarction. Am J Cardiol 1987;60:431-434.
15. Topol EJ: Coronary angioplasty for acute myocardial infarction. Ann Intern Med 1988;109:970-980.
16. Zeymer U, Vogt A, Zahn R, Weber MA, Tebbe U, Gottwik M, Bonzel T, Senges J, Neuhaus KL; The Arbeitsgemeinschaft Leitende Kardiologische Krankenhausarzte (ALKK): Predictors of in-hospital mortality in 1333 patients with acute myocardial infarction complicated by cardiogenic shock treated with primary percutaneous coronary intervention (PCI): results of the primary PCI registry of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausärzte (ALKK). Eur Heart J 2004;25:322-328.
17. The Multicenter Postinfarction Research Group: Risk stratification and survival after myocardial infarction. N Engl J Med 1983;309:331-336.
18. Stack RS, Califf RM, Hinohara T, Phillips HR, Pryor DB, Simonton CA, Carlson EB, Morris KG, Behar VS, Kong Y: Survival and cardiac event rates in the first year after emergency coronary angioplasty for acute myocardial infarction. J Am Coll Cardiol 1988;11:1141-1149.
19. Ellis SG, O'Neill WW, Bates ER, Walton JA Jr, Nabel EG, Werns SW, Topol EJ: Implications for patient triage from survival and left ventricular functional recovery analyses in 500 consecutive patients treated with coronary angioplasty for acute myocardial infarction. J Am Coll Cardiol 1989;13:1251-1259.
20. Topol EJ, Califf RM, George BS, Kereiakes DJ, Abbottsmith CW, Candela RJ, Lee KL, Pitt B, Stack RS, O'Neill WW: A randomized trial of immediate versus delayed elective angioplasty after intravenous tissue plasminogen activator in acute myocardial infarction. N Engl J Med 1987;317:581-588.
21. The TIMI Study Group: Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction. N Engl J Med 1989;320:618-627.
22. Warren SE, Royal HD, Markis JE, Grossman W, McKay RG: Time course of left ventricular dilation after myocardial infarction: influence of infarct-related artery and success of coronary thrombolysis. J Am Coll Cardiol 1988;11:12-19.
23. Kersschot IE, Brugada P, Ramentol M, Zehender M, Waldecker B, Stevenson WG, Geibel A, De Zwaan C, Wellens HJ: Effects of early reperfusion in acute myocardial infarction on arrhythmias induced by programmed stimulation. a prospective randomized study. J Am Coll Cardiol 1986;7:1234-1242.
24. Neumann FJ, Blasini R, Schmitt C, Alt E, Dirschinger J, Gawaz M, Kastrati A, Schomig A: Effect of glycoprotein ιιb/ ιιιa receptor blockade on recovery of coronary of coronary flow and left ventricular function after the placement of coronary-artery stents in acute myocardial infarction. Circulation 1998;98:2695-701.